EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

An Update on Xanomeline-trospium (Cobenfy) for Schizophrenia: Emerging Evidence and Clinical Implications

Amber Rayfield iD, Jessica Dorrough iD, Amanda Herman iD, Sydney Hege iD, Andrew Muzyk iD

Clinical Psychopharmacology and Neuroscience · 30.11.2026 · 24 (4) · 692-700

DOI: 10.9758/cpn.26.1406 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 02.09.2026. Verfasst von Amber Rayfield und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Duke Regional Hospital, Durham, NC, USA. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AcetylcholineAntipsychotic agentsCholinergic agentsPsychotic disordersQuality of life

Autor:innen und Institutionen

  • Department of Pharmacy, Duke Regional Hospital, Durham, NC, USA.
  • Department of Pharmacy, First Health Moore Regional Hospital, Pinehurst, NC, USA.
  • Department of Pharmacy Practice, Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC, USA.
  • Department of Pharmacy, Duke University Hospital, Durham, NC, USA.

ORCID-Profile: Amber Rayfield, Jessica Dorrough, Amanda Herman, Sydney Hege, Andrew Muzyk

Zitieren

APA

Rayfield, A., Dorrough, J., Herman, A., Hege, S., & Muzyk, A. (2026). An Update on Xanomeline-trospium (Cobenfy) for Schizophrenia: Emerging Evidence and Clinical Implications. Clinical Psychopharmacology and Neuroscience, 24(4), 692-700. https://doi.org/10.9758/cpn.26.1406

Vancouver

Rayfield A, Dorrough J, Herman A, Hege S, Muzyk A. An Update on Xanomeline-trospium (Cobenfy) for Schizophrenia: Emerging Evidence and Clinical Implications. Clinical Psychopharmacology and Neuroscience. 2026;24(4):692-700. doi:10.9758/cpn.26.1406

BibTeX
@article{Rayfield2026,
  author = {Rayfield, Amber and Dorrough, Jessica and Herman, Amanda and Hege, Sydney and Muzyk, Andrew},
  title = {An Update on Xanomeline-trospium (Cobenfy) for Schizophrenia: Emerging Evidence and Clinical Implications},
  journal = {Clinical Psychopharmacology and Neuroscience},
  year = {2026},
  volume = {24},
  number = {4},
  pages = {692--700},
  doi = {10.9758/cpn.26.1406}
}
Kostenlos starten →